Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | Technicals | Treasure Chest

Latest Stories

Brokers are excited about the growth prospects of rural transport and logistics company Lindsay Australia as it becomes the number one player in its industry

Sep 13 2023

Tim Boreham highlights a device used to detect pain in non-verbal patients, such as those suffering dementia and infants

Sep 11 2023

Tim Boreham shines a light on freshly listed Cleo Diagnostics, in search of an effective diagnostic tool for ovarian cancer

Aug 30 2023

Let’s talk about the unbreakable bond between households and their pets, and about the companies that offer exposure. Updated with today’s FY23 result release

Aug 28 2023

Previous Stories

Breaking Boundaries: Medical Psychedelics

Aug 21 2023

Australia is the first country in the world to legalise the use of psychedelic drugs for mental illness

Temple & Webster Spends Up For A Bigger Share

Aug 18 2023

Temple & Webster seems destined for strong growth, but at a lower margin as spending increases to grab more market share

USA Market Too Small For Overachieving Life360

Aug 17 2023

Expectations are on the rise for Life360 following second quarter results

Momentum Keeps Building For Avita Medical

Aug 15 2023

Brokers raise target prices for Avita Medical following second quarter results amidst anticipation of exciting prospects in the outlook period

Dr Boreham’s Crucible: IDT Australia

Aug 14 2023

Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market

Stars Are Aligning For SiteMinder

Aug 02 2023

Analysts raise target prices for SiteMinder after management brings forward the time frame for being free cash flow positive

Dr Boreham’s Crucible: Telix Pharmaceuticals

Jul 31 2023

Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports

Syrah Resources: Near-Term Pain, Graphite Price Upside

Jul 20 2023

Analysts remain positive on Syrah Resources despite current weak market conditions for graphite

Dr Boreham’s Crucible: Arovella Therapeutics

Jul 17 2023

Tim Boreham highlights the potential for cancer treatment biotech Arovella Therapeutics

Dr Boreham’s Crucible: PolyNovo

Jul 06 2023

Skin repair specialist PolyNovo remains confident in its firm growth path ahead

Analyse The Market From A Different Angle